SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks
Pharmos(PARS)
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
1491 8 0 PARS
Emcee:  Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
566 FTJoe, It was probably Raloxifene which is LLY's Evista. There are severalHenry Niman-4/7/1998
565 That was it, thanx. eom.FTJoe-4/7/1998
564 FT joe, maybe Raloxifene, from Pfizer and Ligand Rexinoids, Targretin from LigCacaito-4/6/1998
563 To anyone - I was listening to the tamoxifen report with half an ear and missedFTJoe-4/6/1998
562 PARS tamoxiphen derivative. is 1 theoretically more active. yosi s-4/6/1998
561 Stephen -- I saw the Reuters article as well as the upgrade from Furman Selz whKirsten-4/6/1998
560 There is also a story on Reuters about Eli Lilly & Co and theirdrug Evista.Stephen D. Wilson-4/6/1998
559 Just watched the Breast Cancer Prevention Trial news conference on CNN - also rKirsten-4/6/1998
558 Dear Yosi, You're right. In the Matimop website I found (unfortunately undaAriella-4/5/1998
557 Ariella: Please give me your assurances that PARS is not looking for JV partneDavid Israel-Rosen-4/5/1998
556 Thanks Ariella! Just had a chance to read the BBB article which filled in some Kirsten-4/5/1998
555 Interesting links...... a) see item 2 on link. Raphael Mecholam, responsible fAriella-4/5/1998
554 www.Pharmoscorp.comDavid Israel-Rosen-4/5/1998
553 Todd.. Can you supply address of Pharmos web site. Thanks george m. miller-4/5/1998
552 We are getting ahead of ourselves in this thread. For pars tamoxiphen analogeyosi s-4/5/1998
551 Ariella, This indeed is wonderful news for PARS. The reasoning is quite simplE. Todd Phillips-4/5/1998
550 follow up with a URL cnn.comDavid Israel-Rosen-4/5/1998
549 Good news today in general for Tamoxifen: Drug May Prevent Breast Cancer PHILAAriella-4/5/1998
548 Neuroinvestor did not arrive in mail as of today Sat April 4. I guess I should yosi s-4/4/1998
547 Good article. Thanks.Zvi Steinberg-4/4/1998
546 Signals mag features Pharmos and why Israeli biotech is a good invest. www.siMerav-4/4/1998
545 Shalom Yosi, When do you expect the April issue of Neuroinvestor to bo out? CouZvi Steinberg-4/4/1998
544 I can not wait for tobramycin combo with lotemax and alrex. market is biggeyosi s-4/4/1998
543 PARS AND SHORTS My opinion on shorts Since pars is basically a viable companyosi s-4/4/1998
542 Hello: A very good week for PARS is coming. The shorts and other leaches will David Israel-Rosen-4/4/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News